CVE-2024-1032

Public Exploit
openBI Test Connection Databasesource.php testConnection deserialization

Description

A vulnerability classified as critical was found in openBI up to 1.0.8. Affected by this vulnerability is the function testConnection of the file /application/index/controller/Databasesource.php of the component Test Connection Handler. The manipulation leads to deserialization. The attack can be launched remotely. The exploit has been disclosed to the public and may be used. The associated identifier of this vulnerability is VDB-252307.

Category

7.3
CVSS
Severity: High
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.06%
Affected: n/a openBI
Published at:
Updated at:

References

Link Tags
https://vuldb.com/?id.252307 vdb entry permissions required technical description
https://vuldb.com/?ctiid.252307 signature permissions required
https://note.zhaoj.in/share/6ISYe2urjlkI broken link exploit

Frequently Asked Questions

What is the severity of CVE-2024-1032?
CVE-2024-1032 has been scored as a high severity vulnerability.
How to fix CVE-2024-1032?
To fix CVE-2024-1032, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-1032 being actively exploited in the wild?
It is possible that CVE-2024-1032 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-1032?
CVE-2024-1032 affects n/a openBI.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.